Form 8-K - Current report:
SEC Accession No. 0001104659-25-107064
Filing Date
2025-11-05
Accepted
2025-11-05 16:35:30
Documents
14
Period of Report
2025-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pahc-20251104x8k.htm   iXBRL 8-K 60621
2 EX-99.1 pahc-20251104xex99d1.htm EX-99.1 401643
3 GRAPHIC pahc-20251104xex99d1001.jpg GRAPHIC 9566
  Complete submission text file 0001104659-25-107064.txt   615207

Data Files

Seq Description Document Type Size
4 EX-101.SCH pahc-20251104.xsd EX-101.SCH 2667
5 EX-101.LAB pahc-20251104_lab.xml EX-101.LAB 15899
6 EX-101.PRE pahc-20251104_pre.xml EX-101.PRE 10313
16 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20251104x8k_htm.xml XML 4929
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 251454653
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)